Alpha Teknova (TKNO) Cash from Financing Activities (2020 - 2026)
Alpha Teknova (TKNO) posted quarterly Cash from Financing Activities of -$88000.0 for Q1 2026, down 69.23% year-over-year from -$286000.0 in Q1 2025, and down 137.84% quarter-over-quarter from -$37000.0 in Q4 2025.
Alpha Teknova (TKNO) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has reported Cash from Financing Activities for 7 consecutive years, with -$88000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 69.23% year-over-year to -$88000.0; the TTM figure through Mar 2026 stood at $115000.0 (down 99.24% YoY), while the FY2025 annual figure was $151000.0, down 98.99% from the prior year.
- Cash from Financing Activities slipped to -$88000.0 in Q1 2026 per TKNO's latest filing, from -$37000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $15.4 million in Q3 2024 and bottomed at -$621000.0 in Q4 2023.
- Historically, Cash from Financing Activities has averaged $2.2 million across 5 years, with a median of -$28000.0 in 2025.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities jumped 514100.0% — and 2024, when it tumbled 1272.0%.
- Alpha Teknova's Cash from Financing Activities stood at $5.1 million in 2022, then plunged by 112.08% to -$621000.0 in 2023, then soared by 85.99% to -$87000.0 in 2024, then jumped by 57.47% to -$37000.0 in 2025, then tumbled by 137.84% to -$88000.0 in 2026.
- Business Quant data shows TKNO's Cash from Financing Activities at -$88000.0 in Q1 2026, -$37000.0 in Q4 2025, and $268000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -813.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -1.13 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 122.40 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -1.24 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 63.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -74.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alpha Teknova | 374.37 Mn | 356.94 Mn | 4.89 Mn | 224,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 224,000.00 |
| Jun 30, 2026 | 224,000.00 |
| Mar 31, 2026 | -88,000.00 |
| Mar 31, 2026 | -88,000.00 |
| Dec 31, 2025 | -37,000.00 |
| Dec 31, 2025 | -37,000.00 |
| Sep 30, 2025 | 268,000.00 |
| Sep 30, 2025 | 268,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -28,000.00 |
| Mar 31, 2025 | -52,000.00 |
| Mar 31, 2025 | -52,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Dec 31, 2024 | -87,000.00 |
| Sep 30, 2024 | 15.37 Mn |
| Sep 30, 2024 | 15.37 Mn |
| Jun 30, 2024 | -47,000.00 |
| Jun 30, 2024 | -47,000.00 |
| Mar 31, 2024 | -343,000.00 |
| Mar 31, 2024 | -343,000.00 |